_id
69104dfaccc777a4e85d5313
Ticker
CHME
Name
China Medicine Corporation
Exchange
PINK
Address
2/F, Guangri Tower, Guangzhou, China, 510006
Country
USA
Sector
Healthcare
Industry
Medical Distribution
Currency
USD
Website
https://www.cmc621.com/cmc/index.php
Description
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
Last Close
0.04
Volume
95000
Current Price
0.0325
Change
0.01
Last Updated
2026-01-02T11:20:28.037Z
Image
-
Ipo Date
-
Market Cap
9484833
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2010-09-30
Revenue
17550000
Cost Of Revenue
11746000
Gross Profit
5804000
Operating Expenses
3318000
Operating Income
2486000
Interest Expense
78000
Pretax Income
3082000
Net Income
2223000
Eps
0.05614715494940202
Dividends Per Share
-
Shares Outstanding
23712061
Income Tax Expense
941000
EBITDA
2909846
Operating Margin
14.165242165242164
Total Other Income Expense Net
596000
Cash
7854000
Short Term Investments
48474000
Receivables
17273000
Inventories
5867000
Total Current Assets
94198000
Property Plant Equipment
15943000
Total Assets
134045000
Payables
864000
Short Term Debt
3201000
Long Term Debt
-
Total Liabilities
56122000
Equity
77633000
Bs_currency_symbol
USD
Depreciation
423846
Change In Working Capital
-2487884
Cash From Operations
-346561
Capital Expenditures
4434944
Cash From Investing
-3709053
Cash From Financing
2811240
Net Change In Cash
-1150104
Cf_currency_symbol
USD
PE
-
PB
0.016574815381345562
ROE
2.863473007612742
ROA
1.6583982990786676
FCF
-4781505
Fcf Percent
-0.27245042735042735
Piotroski FScore
2
Health Score
48
Deep Value Investing Score
8.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
4.5
Net Net Investing Score
7.5
Quality Investing Score
5
Value Investing Score
7.5
Quarters > 0 > quarter
2010-09-30
Quarters > 0 > income Statement > revenue
17550000
Quarters > 0 > income Statement > cost Of Revenue
11746000
Quarters > 0 > income Statement > gross Profit
5804000
Quarters > 0 > income Statement > operating Expenses
3318000
Quarters > 0 > income Statement > operating Income
2486000
Quarters > 0 > income Statement > interest Expense
78000
Quarters > 0 > income Statement > pretax Income
3082000
Quarters > 0 > income Statement > net Income
2223000
Quarters > 0 > income Statement > eps
0.05614715494940202
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
39592389
Quarters > 0 > income Statement > income Tax Expense
941000
Quarters > 0 > income Statement > EBITDA
2909846
Quarters > 0 > income Statement > operating Margin
14.165242165242164
Quarters > 0 > income Statement > total Other Income Expense Net
596000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
7854000
Quarters > 0 > balance Sheet > short Term Investments
48474000
Quarters > 0 > balance Sheet > receivables
17273000
Quarters > 0 > balance Sheet > inventories
5867000
Quarters > 0 > balance Sheet > total Current Assets
94198000
Quarters > 0 > balance Sheet > property Plant Equipment
15943000
Quarters > 0 > balance Sheet > total Assets
134045000
Quarters > 0 > balance Sheet > payables
864000
Quarters > 0 > balance Sheet > short Term Debt
3201000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
56122000
Quarters > 0 > balance Sheet > equity
77633000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
2140755
Quarters > 0 > cash Flow > depreciation
423846
Quarters > 0 > cash Flow > change In Working Capital
-2487884
Quarters > 0 > cash Flow > cash From Operations
-346561
Quarters > 0 > cash Flow > capital Expenditures
4434944
Quarters > 0 > cash Flow > cash From Investing
-3709053
Quarters > 0 > cash Flow > cash From Financing
2811240
Quarters > 0 > cash Flow > net Change In Cash
-1150104
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.05614715494940202
Quarters > 0 > ratios > PB
0.016574815381345562
Quarters > 0 > ratios > ROE
2.863473007612742
Quarters > 0 > ratios > ROA
1.6583982990786676
Quarters > 0 > ratios > FCF
-4781505
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.27245042735042735
Quarters > 0 > health Score
48
Quarters > 1 > quarter
2010-06-30
Quarters > 1 > income Statement > revenue
17190087
Quarters > 1 > income Statement > cost Of Revenue
11082645
Quarters > 1 > income Statement > gross Profit
6107442
Quarters > 1 > income Statement > operating Expenses
2318776
Quarters > 1 > income Statement > operating Income
3788666
Quarters > 1 > income Statement > interest Expense
77663
Quarters > 1 > income Statement > pretax Income
5114189
Quarters > 1 > income Statement > net Income
4103325
Quarters > 1 > income Statement > eps
0.10260184214105258
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
39992703
Quarters > 1 > income Statement > income Tax Expense
1089308
Quarters > 1 > income Statement > EBITDA
4255591
Quarters > 1 > income Statement > operating Margin
22.039830281254538
Quarters > 1 > income Statement > total Other Income Expense Net
1325523
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
9004104
Quarters > 1 > balance Sheet > short Term Investments
53890000
Quarters > 1 > balance Sheet > receivables
24877145
Quarters > 1 > balance Sheet > inventories
3883201
Quarters > 1 > balance Sheet > total Current Assets
99237324
Quarters > 1 > balance Sheet > property Plant Equipment
11550038
Quarters > 1 > balance Sheet > total Assets
135142557
Quarters > 1 > balance Sheet > payables
2523532
Quarters > 1 > balance Sheet > short Term Debt
4873052
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
61845600
Quarters > 1 > balance Sheet > equity
72931046
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
4024881
Quarters > 1 > cash Flow > depreciation
466925
Quarters > 1 > cash Flow > change In Working Capital
-6835004
Quarters > 1 > cash Flow > cash From Operations
-3506140
Quarters > 1 > cash Flow > capital Expenditures
108039
Quarters > 1 > cash Flow > cash From Investing
-38915
Quarters > 1 > cash Flow > cash From Financing
1418524
Quarters > 1 > cash Flow > net Change In Cash
-2082693
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.10260184214105258
Quarters > 1 > ratios > PB
0.017821804550835593
Quarters > 1 > ratios > ROE
5.626307622133926
Quarters > 1 > ratios > ROA
3.0362937412824
Quarters > 1 > ratios > FCF
-3614179
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.21024785971123938
Quarters > 1 > health Score
51
Quarters > 2 > quarter
2010-03-31
Quarters > 2 > income Statement > revenue
10572289
Quarters > 2 > income Statement > cost Of Revenue
7324901
Quarters > 2 > income Statement > gross Profit
3247388
Quarters > 2 > income Statement > operating Expenses
2001060
Quarters > 2 > income Statement > operating Income
1246328
Quarters > 2 > income Statement > interest Expense
94213
Quarters > 2 > income Statement > pretax Income
2235319
Quarters > 2 > income Statement > net Income
1797805
Quarters > 2 > income Statement > eps
0.09513656037892378
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
18897099
Quarters > 2 > income Statement > income Tax Expense
512955
Quarters > 2 > income Statement > EBITDA
1708557
Quarters > 2 > income Statement > operating Margin
11.788629690315881
Quarters > 2 > income Statement > total Other Income Expense Net
988991
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
11086797
Quarters > 2 > balance Sheet > short Term Investments
61859000
Quarters > 2 > balance Sheet > receivables
21525638
Quarters > 2 > balance Sheet > inventories
3703727
Quarters > 2 > balance Sheet > total Current Assets
102344417
Quarters > 2 > balance Sheet > property Plant Equipment
11732618
Quarters > 2 > balance Sheet > total Assets
138541840
Quarters > 2 > balance Sheet > payables
2654803
Quarters > 2 > balance Sheet > short Term Debt
11413260
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
77649531
Quarters > 2 > balance Sheet > equity
60447969
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
1722364
Quarters > 2 > cash Flow > depreciation
462229
Quarters > 2 > cash Flow > change In Working Capital
350887
Quarters > 2 > cash Flow > cash From Operations
1428701
Quarters > 2 > cash Flow > capital Expenditures
64017
Quarters > 2 > cash Flow > cash From Investing
-77032
Quarters > 2 > cash Flow > cash From Financing
9257236
Quarters > 2 > cash Flow > net Change In Cash
10615028
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.09513656037892378
Quarters > 2 > ratios > PB
0.010160072003411727
Quarters > 2 > ratios > ROE
2.9741363187901317
Quarters > 2 > ratios > ROA
1.2976621358572977
Quarters > 2 > ratios > FCF
1364684
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.1290812235647361
Quarters > 2 > health Score
54
Quarters > 3 > quarter
2009-12-31
Quarters > 3 > income Statement > revenue
20441590
Quarters > 3 > income Statement > cost Of Revenue
13599386
Quarters > 3 > income Statement > gross Profit
6842204
Quarters > 3 > income Statement > operating Expenses
2659002
Quarters > 3 > income Statement > operating Income
4183202
Quarters > 3 > income Statement > interest Expense
94213
Quarters > 3 > income Statement > pretax Income
-948862
Quarters > 3 > income Statement > net Income
-2094507
Quarters > 3 > income Statement > eps
-0.1359085555528663
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
15411149
Quarters > 3 > income Statement > income Tax Expense
1218223
Quarters > 3 > income Statement > EBITDA
4531706
Quarters > 3 > income Statement > operating Margin
20.464171329138292
Quarters > 3 > income Statement > total Other Income Expense Net
-5132064
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
471769
Quarters > 3 > balance Sheet > short Term Investments
1760000
Quarters > 3 > balance Sheet > receivables
22319061
Quarters > 3 > balance Sheet > inventories
2731097
Quarters > 3 > balance Sheet > total Current Assets
30261729
Quarters > 3 > balance Sheet > property Plant Equipment
12000687
Quarters > 3 > balance Sheet > total Assets
66844482
Quarters > 3 > balance Sheet > payables
1324269
Quarters > 3 > balance Sheet > short Term Debt
9506160
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
21335490
Quarters > 3 > balance Sheet > equity
44989185
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2167085
Quarters > 3 > cash Flow > depreciation
348504
Quarters > 3 > cash Flow > change In Working Capital
10061131
Quarters > 3 > cash Flow > cash From Operations
13431217
Quarters > 3 > cash Flow > capital Expenditures
30669
Quarters > 3 > cash Flow > cash From Investing
-6478179
Quarters > 3 > cash Flow > cash From Financing
-8731089
Quarters > 3 > cash Flow > net Change In Cash
-1770812
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.1359085555528663
Quarters > 3 > ratios > PB
0.011132949896736294
Quarters > 3 > ratios > ROE
-4.655578890793421
Quarters > 3 > ratios > ROA
-3.133402993533557
Quarters > 3 > ratios > FCF
13400548
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.6555531149974145
Quarters > 3 > health Score
53
Annuals > 0 > quarter
2009-12-31
Annuals > 0 > income Statement > revenue
64751018
Annuals > 0 > income Statement > cost Of Revenue
45766628
Annuals > 0 > income Statement > gross Profit
18984390
Annuals > 0 > income Statement > operating Expenses
6718099
Annuals > 0 > income Statement > operating Income
12266291
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
4951826
Annuals > 0 > income Statement > net Income
1717677
Annuals > 0 > income Statement > eps
0.11145681332936737
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
15411144
Annuals > 0 > income Statement > income Tax Expense
3549680
Annuals > 0 > income Statement > EBITDA
13278440
Annuals > 0 > income Statement > operating Margin
18.943780930208696
Annuals > 0 > income Statement > total Other Income Expense Net
-7314465
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
471769
Annuals > 0 > balance Sheet > short Term Investments
1760000
Annuals > 0 > balance Sheet > receivables
22319061
Annuals > 0 > balance Sheet > inventories
2731097
Annuals > 0 > balance Sheet > total Current Assets
30261729
Annuals > 0 > balance Sheet > property Plant Equipment
12000687
Annuals > 0 > balance Sheet > total Assets
66844482
Annuals > 0 > balance Sheet > payables
1324269
Annuals > 0 > balance Sheet > short Term Debt
9506160
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
21335490
Annuals > 0 > balance Sheet > equity
44989185
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
1402146
Annuals > 0 > cash Flow > depreciation
1012149
Annuals > 0 > cash Flow > change In Working Capital
7114395
Annuals > 0 > cash Flow > cash From Operations
16959384
Annuals > 0 > cash Flow > capital Expenditures
3673500
Annuals > 0 > cash Flow > cash From Investing
-13536093
Annuals > 0 > cash Flow > cash From Financing
-5749289
Annuals > 0 > cash Flow > net Change In Cash
-2320045
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.11145681332936737
Annuals > 0 > ratios > PB
0.013702087735085666
Annuals > 0 > ratios > ROE
3.8179775872801427
Annuals > 0 > ratios > ROA
2.5696616214334638
Annuals > 0 > ratios > FCF
13285884
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.20518417177626458
Annuals > 0 > health Score
73
Annuals > 1 > quarter
2008-12-31
Annuals > 1 > income Statement > revenue
53647806
Annuals > 1 > income Statement > cost Of Revenue
38074919
Annuals > 1 > income Statement > gross Profit
15572887
Annuals > 1 > income Statement > operating Expenses
4645022
Annuals > 1 > income Statement > operating Income
10927865
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
11013487
Annuals > 1 > income Statement > net Income
9125616
Annuals > 1 > income Statement > eps
0.5961131863159419
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
15308529
Annuals > 1 > income Statement > income Tax Expense
2006137
Annuals > 1 > income Statement > EBITDA
11348634
Annuals > 1 > income Statement > operating Margin
20.36964009301704
Annuals > 1 > income Statement > total Other Income Expense Net
85622
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2791814
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
19826002
Annuals > 1 > balance Sheet > inventories
4725322
Annuals > 1 > balance Sheet > total Current Assets
33657192
Annuals > 1 > balance Sheet > property Plant Equipment
3761637
Annuals > 1 > balance Sheet > total Assets
44681316
Annuals > 1 > balance Sheet > payables
61243
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1079523
Annuals > 1 > balance Sheet > equity
42766261
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
9125616
Annuals > 1 > cash Flow > depreciation
420769
Annuals > 1 > cash Flow > change In Working Capital
-5353342
Annuals > 1 > cash Flow > cash From Operations
4209084
Annuals > 1 > cash Flow > capital Expenditures
2666014
Annuals > 1 > cash Flow > cash From Investing
-7863267
Annuals > 1 > cash Flow > cash From Financing
362500
Annuals > 1 > cash Flow > net Change In Cash
-2975960
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.5961131863159419
Annuals > 1 > ratios > PB
0.014318323502725666
Annuals > 1 > ratios > ROE
21.338353614780587
Annuals > 1 > ratios > ROA
20.423785190212392
Annuals > 1 > ratios > FCF
1543070
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.02876296562808179
Annuals > 1 > health Score
75
Annuals > 2 > quarter
2007-12-31
Annuals > 2 > income Statement > revenue
42105387
Annuals > 2 > income Statement > cost Of Revenue
29708088
Annuals > 2 > income Statement > gross Profit
12397299
Annuals > 2 > income Statement > operating Expenses
3982897
Annuals > 2 > income Statement > operating Income
8414402
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
8429825
Annuals > 2 > income Statement > net Income
6875369
Annuals > 2 > income Statement > eps
0.5033947485896002
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
13658007
Annuals > 2 > income Statement > income Tax Expense
1649114
Annuals > 2 > income Statement > EBITDA
9198516
Annuals > 2 > income Statement > operating Margin
19.98414597163066
Annuals > 2 > income Statement > total Other Income Expense Net
15423
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5767774
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
13626347
Annuals > 2 > balance Sheet > inventories
3948460
Annuals > 2 > balance Sheet > total Current Assets
29407079
Annuals > 2 > balance Sheet > property Plant Equipment
1388919
Annuals > 2 > balance Sheet > total Assets
32640238
Annuals > 2 > balance Sheet > payables
76907
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
862718
Annuals > 2 > balance Sheet > equity
30884183
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
6875369
Annuals > 2 > cash Flow > depreciation
784114
Annuals > 2 > cash Flow > change In Working Capital
-10072833
Annuals > 2 > cash Flow > cash From Operations
-2310113
Annuals > 2 > cash Flow > capital Expenditures
389588
Annuals > 2 > cash Flow > cash From Investing
-389588
Annuals > 2 > cash Flow > cash From Financing
7829681
Annuals > 2 > cash Flow > net Change In Cash
5396294
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.5033947485896002
Annuals > 2 > ratios > PB
0.017689322719011216
Annuals > 2 > ratios > ROE
22.261780407142385
Annuals > 2 > ratios > ROA
21.06408966748343
Annuals > 2 > ratios > FCF
-2699701
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.06411771016378498
Annuals > 2 > health Score
73
Annuals > 3 > quarter
2006-12-31
Annuals > 3 > income Statement > revenue
23991950
Annuals > 3 > income Statement > cost Of Revenue
15017100
Annuals > 3 > income Statement > gross Profit
8974850
Annuals > 3 > income Statement > operating Expenses
2790638
Annuals > 3 > income Statement > operating Income
6184212
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
5984267
Annuals > 3 > income Statement > net Income
4787874
Annuals > 3 > income Statement > eps
0.6255728035388388
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
7653584
Annuals > 3 > income Statement > income Tax Expense
1229688
Annuals > 3 > income Statement > EBITDA
6346263
Annuals > 3 > income Statement > operating Margin
25.77619576566307
Annuals > 3 > income Statement > total Other Income Expense Net
-199945
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
371480
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
7034911
Annuals > 3 > balance Sheet > inventories
1900467
Annuals > 3 > balance Sheet > total Current Assets
13426406
Annuals > 3 > balance Sheet > property Plant Equipment
1215311
Annuals > 3 > balance Sheet > total Assets
14642399
Annuals > 3 > balance Sheet > payables
188877
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
600027
Annuals > 3 > balance Sheet > equity
13133892
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
4787874
Annuals > 3 > cash Flow > depreciation
162051
Annuals > 3 > cash Flow > change In Working Capital
-7955573
Annuals > 3 > cash Flow > cash From Operations
-2218208
Annuals > 3 > cash Flow > capital Expenditures
826490
Annuals > 3 > cash Flow > cash From Investing
-826490
Annuals > 3 > cash Flow > cash From Financing
3488906
Annuals > 3 > cash Flow > net Change In Cash
279516
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.6255728035388388
Annuals > 3 > ratios > PB
0.023309416584208244
Annuals > 3 > ratios > ROE
36.45434270359464
Annuals > 3 > ratios > ROA
32.69869916808032
Annuals > 3 > ratios > FCF
-3044698
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.12690498271295164
Annuals > 3 > health Score
73
Valuation > metrics > PE
0.05614715494940202
Valuation > metrics > PB
0.016574815381345562
Valuation > final Score
90
Valuation > verdict
98.9% Undervalued
Profitability > metrics > ROE
2.863473007612742
Profitability > metrics > ROA
2.359922715981231
Profitability > metrics > Net Margin
0.12666666666666668
Profitability > final Score
32
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.722914224620973
Risk > metrics > Interest Coverage
31.871794871794872
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
23.172939729397292
Liquidity > metrics > Quick Ratio
21.729643296432965
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
70
Prev Profitabilities > 0
54
Prev Profitabilities > 1
37
Prev Profitabilities > 2
0
Prev Risks > 0
88
Prev Risks > 1
70
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:35:52.430Z
Earnings History > 0 > period
2010-09-30
Earnings History > 0 > report Date
2010-09-30
Earnings History > 0 > date
2010-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
0.0561
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2010-06-30
Earnings History > 1 > report Date
2010-06-30
Earnings History > 1 > date
2010-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
0.1026
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2010-03-31
Earnings History > 2 > report Date
2010-03-31
Earnings History > 2 > date
2010-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.23
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2009-12-31
Earnings History > 3 > report Date
2009-12-31
Earnings History > 3 > date
2009-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.1361
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2009-09-30
Earnings History > 4 > report Date
2009-09-30
Earnings History > 4 > date
2009-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.2089
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2009-06-30
Earnings History > 5 > report Date
2009-06-30
Earnings History > 5 > date
2009-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.0027
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2009-03-31
Earnings History > 6 > report Date
2009-03-31
Earnings History > 6 > date
2009-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.0361
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2008-12-31
Earnings History > 7 > report Date
2008-12-31
Earnings History > 7 > date
2008-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.2144
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2008-09-30
Earnings History > 8 > report Date
2008-09-30
Earnings History > 8 > date
2008-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.1264
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2008-06-30
Earnings History > 9 > report Date
2008-06-30
Earnings History > 9 > date
2008-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.1577
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2008-03-31
Earnings History > 10 > report Date
2008-03-31
Earnings History > 10 > date
2008-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.0767
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2007-12-31
Earnings History > 11 > report Date
2007-12-31
Earnings History > 11 > date
2007-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.1965
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2007-09-30
Earnings History > 12 > report Date
2007-09-30
Earnings History > 12 > date
2007-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.1415
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2007-06-30
Earnings History > 13 > report Date
2007-06-30
Earnings History > 13 > date
2007-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.0792
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2007-03-31
Earnings History > 14 > report Date
2007-03-31
Earnings History > 14 > date
2007-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.0596
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2006-12-31
Earnings History > 15 > report Date
2006-12-31
Earnings History > 15 > date
2006-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.3129
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AReport: Chime Set to Launch IPO Thursday, Aiming for $11 Billion Valuation PYMNTS.com
Read more →Showing 2 of 5
(Last Updated 2010-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of China Medicine Corporation
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2010-09-30
EPS Actual
0.0561
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2010-09-30)
(Last Updated 2010-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2010-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2010-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.